Korea’s Green Cross to Build Cell Therapy Facility in China

ChinaBio® Daily Update


Korea’s Green Cross to Build Cell Therapy Facility in China

Written by Richard Daverman, PhD, Executive Editor, Greg B. Scott.

Green Cross of South Korea will build a new cell therapy manufacturing facility in the Guian New Area of Guizhou province, located in China’s southwest corner. In South Korea, the company already produces cell therapy projects including T cell, NK cell, dendritic cell and stem cells. The new China facility will offer cellular therapeutic products for clinical studies and commercial supply, in response, the company says, to the increasing global interest in cellular therapeutic drugs as treatments for serious diseases. More details…. 

Stock Symbol: (KRX: 5280)

Share this with colleagues: 


More Recent Articles

Written by Richard Daverman, PhD, Executive Editor, Greg B. Scott.

Scanadu Raises $35 Million from China Investors for Mobile Diagnostic DeviceShenzhen Hepalink Pharma Enters $441 Million Deal for Resverlogix CV DrugChina Cord Blood Receives $512 Million Take-Private OfferWeek in Review: Haohai Biological Schedules $305 Million Hong Kong IPOFor Big Pharma in China, Innovation is in the Eye of the Beholder

Partner Events

Asia Biotech Invest 2015

May 19-21, 2015
Hong Kong, China

 Not a ChinaBio®Today Subscriber?

Here’s what you get with a paid subscription to ChinaBio® Today:

Website access to all current articles and commentaryFull access to over 2000 archived articles on the biotech industry

Greg B. Scott
Executive Editor
ChinaBio® Today 

ChinaBio and ChinaBio Today are trademarks of ChinaBio LLC

Related Post

Highlights on the New Findings on LRS Published in...
views 161
The article that was published in Cell is getting spotlights from other journals. So far, Molecular Cell, Science Signaling, Cell research included th...
A paper on a new ARS receptor was published in the...
views 155
Dr. Hyuck Sang Kwon's article was published in the Journal of Cell Science for discovering  a new AIMP1 receptor.   The title of the article...
류성호 한정민 교수 LRS논문 Cell에 정식게재...
views 189
The collaboration work with prof. Sung Ho Ryu regarding LRS was publisehd in Cell officially.Last month, the LRS article was published in early online...

Leave a reply

Your email address will not be published. Required fields are marked *



We're not around right now. But you can send us an email and we'll get back to you, asap.


©2010-2017 Medicinal Bioconvergence Research Center. All rights reserved.

Log in with your credentials

Forgot your details?

Skip to toolbar